24 June 2015
What Is the Role of the Gut Microbiome in Developing Parkinson’s Disease?
In recent years, an important Parkinson’s disease (PD) research focus has been on gut-related pathology, pathophysiology, and symptoms. Gastrointestinal dysfunction, in particular constipation, affects up to 80% of PD patients and idiopathic constipation is one of the strongest risk-factors for PD. Lifestyle factors such as smoking and coffee consumption, as well as blood urate levels, have been associated with a decreased PD risk.
Old Contact
Head Office
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0019
info@iospress.nl
For questions about submission and review of papers:
Contact information after acceptance of the paper:
For editorial matters:
editorial@iospress.nl
For publisher matters, copyright and permissions:
publisher@iospress.nl
For placing orders, claims, questions regarding existing orders, invoices etc:
order@iospress.nl
For press, marketing and promotion matters:
market@iospress.nl
For all other matters:
info@iospress.nl
Aims and Scope
The Journal of Parkinson’s Disease is dedicated to providing an open forum for original research in basic science, translational research and clinical medicine that will expedite our fundamental understanding and improve treatment of Parkinson’s disease. The journal is international and multidisciplinary and aims to promote progress in the epidemiology, etiology, genetics, molecular correlates, pathogenesis, pharmacology, psychology, diagnosis and treatment of Parkinson’s disease. It will publish research reports, reviews, short communications, and letters-to-the-editor and offers very rapid publication and affordable open access.
Editorial Board
Editors-in-Chief
Bas Bloem, MD, PhD, FRCPE
Center of Expertise for Parkinson & Movement Disorders
Radboud University Medical Centre
Nijmegen, the Netherlands
Email: bas.bloem@iospress.com
Lorraine V. Kalia, MD, PhD, FRCPC
Division of Neurology, Department of Medicine
University of Toronto
Toronto, ON, Canada
Email: l.kalia@iospress.com
Editors-in-Chief Emeritus
Patrik Brundin, MD, PhD
Roche, Grand Rapids, MI, USA
J. William Langston, MD
Stanford University, Palo Alto, CA, USA
Associate Editor for Reviews
Rodolfo Savica
Department of Neurology, Mayo Clinic, Rochester, USA
Tiago Fleming Outeiro
Georg-August-Universität Göttingen, Göttingen, Germany
Associate Editors
Roy N. Alcalay
Columbia University, New York, USA
Roger Barker
University of Cambridge, Cambridge, United Kingdom
Erwan Bezard
University of Bordeaux, Bordeaux, France
Roongroj Bhidayasiri
Chulalongkorn University, Bangkok, Thailand
Camille B. Carroll
University of Plymouth, Plymouth, United Kingdom
Mark R. Cookson
NIH, Bethesda, USA
Kelly D. Foote
University of Florida/Fixel Institute for Neurological Diseases, Gainesville, USA
Ziv Gan-Or
Montreal Neurological Institute, McGill University, Montreal, Canada
Glenda Halliday
The University of Sydney, Sydney, Australia
Nobutaka Hattori
Juntendo University School of Medicine, Tokyo, Japan
Jeffrey H. Kordower
Rush University, Chicago, USA
Tilo Kunath
University of Edinburgh, Edinburgh, UK
Matthew J. Lavoie
The University of Florida College of Medicine, Florida, USA
Simon J.G. Lewis
Macquarie University , Sydney, NSW, Australia
Tim Lynch
Dublin Neurological Institute at the Mater Hospital, University College Dublin, Dublin, Ireland
Anat Mirelman
Department of Neurology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Caroline Moreau
Expert Center for Parkinson's Disease, University Hospital of Lille, Lille, France
Alice Nieuwboer
Catholic University Leuven, Leuven, Belgium
Alastair Noyce
Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, United Kingdom
Laurie H. Sanders
Department of Neurology, Duke University School of Medicine, Durham, NC, USA
Rick Schuurman
Amsterdam University Medical Centers, Amsterdam, the Netherlands
Antonio Strafella
Krembil Research Institute, Toronto, ON, Canada
Eng King Tan
Duke NUS Graduate Medical School, Singapore, Singapore
Aleksandar Videnovic
Massachusetts General Hospital, Harvard Medical School, Boston, USA
Nienke M. de Vries
Center of Expertise for Parkinson and Movement Disorders, Radboud University Medical Centre, Nijmegen, the Netherlands
Doris Wang
Neurological Surgery, School of Medicine, University of California, San Francisco, USA
Amanda L. Woerman
Department of Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, CO, USA
Cornelis Blauwendraat, PhD
Integrative Neurogenomics Unit, National Institute on Aging, Bethesda, MD, USA
Suneil Kalia, MD, PhD
Department of Surgery, University of Toronto, Toronto, ON, Canada
Associate Editors of Clinical Trials Highlights
Kevin McFarthing
Parkinson’s Advocate, Innovation Fixer Ltd, Oxford, UK
Tanya Simuni
Parkinson's Disease and Movement Disorders Center,
Northwestern University Feinberg School of Medicine, Chicago, USA
Associate Editor of Hidden Gems
Peter A. LeWitt
Department of Neurology, Wayne State University School of Medicine, Detroit, MI, USA
Associate Editor for Statistics
Jeremy Syrjanen
Department of Quantitative Health Sciences, Mayo Clinic, Rochester, USA
Managing Editor
Beth Kumar
Case Western Reserve University, Cleveland, USA
Email: jpd@iospress.com
Editorial Board
Dag Aarsland
University of Stavanger, Stavanger, Norway
Asa Abeliovich
Columbia University College of Physicians & Surgeons, New York, USA
Yves Agid
Institut du Cerveau et de la Moelle épinière, Paris, France
Alberto Albanese
National Neurological Hospital Carlo Besta, Milan, Italy
Ernest Arenas
Karolinska Institute, Stockholm, Sweden
Alberto Ascherio
Harvard School of Public Health, Boston, USA
Alim Benabid
University of Grenoble, Grenoble, France
Daniela Berg
Christian-Albrechts-Universität zu Kiel, Kiel, Germany
Hagai Bergman
The Hebrew University, Jerusalem, Israel
Erwan Bezard
University of Bordeaux, Bordeaux, France
Anders Björklund
Lund University, Lund, Sweden
Vincenzo Bonifati
Erasmus MC, Rotterdam, the Netherlands
Heiko Braak
University of Ulm, Ulm, Germany
Jose Bras
University College London, London, UK
Alexis Brice
Pierre and Marie Curie University, Paris, France
Helen Bronte-Stewart
Stanford University, Palo Alto, USA
David J. Brooks
Hammersmith Hospital, London, United Kingdom
Paolo Calabresi
Policlinico Gemelli, Catholic University, Rome, Italy
M. Angela Cenci Nilsson
Lund University, Lund, Sweden
Piu Chan
Beijing Institute of Geriatrics, Beijing, China
K. Ray Chaudhuri
Kings College Hospital, London, United Kingdom
Marie Francoise Chesselet
University of California Los Angeles, Los Angeles, USA
Cynthia Comella
Rush University Medical Center, Chicago, USA
Ted M. Dawson
Johns Hopkins University School of Medicine, Baltimore, USA
Valina L. Dawson
Johns Hopkins University School of Medicine, Baltimore, USA
Benjamin Dehay
University of Bordeaux, Bordeaux, France
Steve DeWitte
Connecticut Advocates for Parkinson's, New Preston Marble Dale, USA
Dennis Dickson
Mayo Clinic, Scottsdale, USA
Robert H. Edwards
University of California San Francisco, San Francisco, USA
David Eidelberg
The Feinstein Institute for Medical Research, New York, USA
Omar M. El-Agnaf
United Arab Emirates University, Al-Ain, United Arab Emirates
Alberto Espay
University of Cincinatti, Cincinatti, USA
Stanley Fahn
Columbia University College of Physicians & Surgeons, New York, USA
Matt Farrer
University of British Columbia, Vancouver, Canada
Howard Federoff
Georgetown University, Washington, USA
Joaquim Ferreira
Hospital de Santa Maria, Lisbon, Portugal
Tom Foltynie
University College London, London, UK
Thomas Gasser
University of Tuebingen, Tuebingen, Germany
Larry Gifford
PD Avengers, Vancouver, BC, Canada
Nir Giladi
Tel Aviv University, Tel Aviv, Israel
Ann M. Graybiel
MIT, Cambridge, USA
J. Timothy Greenamyre
University of Pittsburgh, Pittsburgh, USA
James G. Greene
Emory University, Atlanta, USA
Rita Guerreiro
University College London, London, UK
Mark Hallett
NIH, Bethesda, USA
John Hardy
University College London, London, United Kingdom
Etienne C. Hirsch
Centre de Recherche de l'Institut du Cerveau et de la Moelle épinière, Paris, France
Joseph Jankovic
Baylor College of Medicine, Houston, USA
Christine Klein
University of Lübeck, Lübeck, Germany
Han Seok Ko
Johns Hopkins, Baltimore, USA
Amos D. Korczyn
Tel Aviv University, Ramat Aviv, Israel
Dimitri Krainc
Northwestern University, Chicago, USA
Emma L. Lane
Cardiff University, Cardiff, Wales, UK
Seung-Jae Lee
Konkuk University, Seoul, South Korea
Virginia Lee
University of Pennsylvania School of Medicine, Philadelphia, USA
Peter A. LeWitt
Wayne State University, Detroit, USA
Henry Ford Hospital, Detroit, USA
Olle Lindvall
Lund University, Lund, Sweden
Andres Lozano
University of Toronto, Toronto, Canada
Laura Marsh
Baylor College of Medicine, Houston, USA
Ian Martin
Oregon Health & Science University, Portland, USA
Soania Mathur
Designing a Cure Inc., Toronto, Canada
Mark P. Mattson
Johns Hopkins University School of Medicine, Baltimore, USA
Wassilios Meissner
University Hospital Bordeaux, Bordeaux, France
Darren Moore
Van Andel Institute, Grand Rapids, USA
Robert Nussbaum
University of California San Francisco, San Francisco, USA
Tiago Outeiro
University Medical Center Göttingen, Göttingen, Germany
Jon Palfreman
University of Oregon, Eugene, USA
Ronald F. Pfeiffer
Oregon Health and Sciences University, Portland, USA
Serge Przedborski
Columbia University Medical Center, New York, USA
Heinz Reichmann
University of Dresden, Dresden, Germany
Tamas Revesz
University College London, London, United Kingdom
Olaf Riess
University of Tuebingen, Tuebingen, Germany
Trevor Robbins
University of Cambridge, Cambridge, United Kingdom
Marina Romero Ramos
Aarhus University, Aarhus, Denmark
Anthony Schapira
University College London, London, United Kingdom
Sonja Scholz
NIH, Bethesda, USA
Jie Shen
Harvard Medical School, Boston, USA
Todd Sherer
Michael J. Fox Foundation, New York, USA
Ira Shoulson
Georgetown University, Washington, USA
Andrew Singleton
NIH, Bethesda, USA
Richard Smeyne
Thomas Jefferson University, Philadelphia, USA
Yoland Smith
Emory University, Atlanta, USA
Jon Stamford
Parkinson's Movement & The Cure Parkinson's Trust, London, United Kingdom
David G. Standaert
University of Alabama at Birmingham, Birmingham, USA
Leonidas Stefanis
University of Athens Medical School, Athens, Greece
Dennis Steindler
University of Florida, Gainesville, USA
Benjamin Stecher
tmrwedition.com, Toronto, Canada
Fabrizio Stocchi
IRCCS San Raffaele, Rome, Italy
A. Jon Stoessl
University of British Columbia, Vancouver, Canada
David L Sulzer
Columbia University, New York, USA
James Dalton Surmeier
Northwestern University, Chicago, USA
Michele Tagliati
Cedars-Sinai Medical Center, Los Angeles, USA
Jun Takahashi
Kyoto University, Kyoto, Japan
Caroline M. Tanner
The Parkinson's Institute and Clinical Center, Sunnyvale, USA
Malú G Tansey
University of Florida College of Medicine, Gainesville, USA
Bobby Thomas
Medical University of South Carolina, Charleston, USA
Eduardo Tolosa
University of Barcelona, Barcelona, Spain
Jens Volkmann
Universitätsklinikum Wurzburg, Wurzburg, Germany
Laura Volpicelli-Daley
The University of Alabama at Birmingham, Birmingham, USA
Daniel Weintraub
University of Pennsylvania, Philadelphia, USA
Nick Wood
University College London, London, United Kingdom
Zhenyu Yue
Icahn School of Medicine at Mount Sinai, New York, USA
Hannington Kabugo
Parkinson's si Buko Uganda, Kampala, Uganda
David J Blacker
Perron Institute for neurological and translational science, Nedlands, Australia
Founding Editors from the Journal of Alzheimer’s Disease
George Perry
University of Texas at San Antonio, San Antonio, USA
Mark A. Smith†
Case Western Reserve University, Cleveland, USA
Advertising
Please contact market@iospress.nl for your advertising proposals and requests.
About the Journal
The Journal of Parkinson's Disease (JPD) publishes original research in basic science, translational research and clinical medicine in Parkinson’s disease in cooperation with the Journal of Alzheimer's Disease. It features a first class Editorial Board and provides rigorous peer review and rapid online publication.
Publication
From 2022, the journal publishes eight issues per annual volume; prior to this it was four issues per year. From 2023 the journal will proceed as an open access publication, where all articles from the 2023 volume onwards will be openly available.
Impact Factor
JPD has a Journal Impact Factor of 5.2, and a CiteScore of 6.9 (2023 Journal Citation Reports, source: Clarivate, 2023).
Abstracted/Indexed in
Chemical Abstracts Service (CAS), Embase, Journal Citation Reports/Science Edition, MEDLINE, PsycINFO, PubsHub, Science Citation Index-Expanded (SciSearch®), Scopus
News & Social Media
View a selection of newsletters that were sent out recently by clicking on the links:
2020: Issue 1; Issue 2; Issue 3; Issue 4; Special Issue; Parkinson Prize 2020
To receive news and JAD updates, sign up via this link: http://tiny.cc/JPDsignup
Find JPD on Facebook at: facebook.com/journalpd
Follow JPD on Twitter at: twitter.com/journal_pd
The Publisher
IOS Press publishes publishes around 90 journals and 70 books annually in a broad range of subject categories, primarily specializing in biomedical and life sciences (including neurosciences, medical informatics, cancer research, rehabilitation) and physical sciences (including computer sciences, artificial intelligence, engineering).
Headquartered in Amsterdam with satellite offices in the USA, Germany and China, IOS Press continues its rapid growth, embracing new technologies for the timely dissemination of information.
All journals are available in print and electronic format.
